PRKCD and hepatocellular carcinoma: Clinical studies have shown that serum PKCδ levels are significantly higher in patients with hepatocellular carcinoma (HCC) than in normal individuals or those with chronic liver disease (chronic hepatitis and cirrhosis) [8].